Tenders of National University Corporation
Tenders of National University Corporation
National University Corporation Tender
Healthcare and Medicine
Japan
①faricimab (genetical Recombination) 28.8mg 127 Vials,②satralizumab (genetical Recombination) 120mg 24 Vials,③ravulizumab (genetical Recombination) 300mg 45 Vials,④epcoritamab (genetical Recombination) 48mg 12 Vials
Closing Date13 Apr 2025
Tender AmountRefer Documents
121-130 of 159 active Tenders